Department of Cardiology, CCU, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China.
Trials. 2024 Oct 18;25(1):694. doi: 10.1186/s13063-024-08553-4.
Valvular heart disease is the third most common cardiovascular disease; it significantly diminishes patients' quality of life and imposes burdens on individuals, families, and healthcare systems. In recent years, psycho-cardiology has emerged as a prominent field in which to explore the link between mental illness and heart disease. This mixed-method study aims to assess the effectiveness of the WCPP, which includes hospital-to-home transitional care, remote intelligent monitoring, and decision aids, in improving the physical and mental health of patients.
A mixed-method study was conducted at a cardiac valve interventional surgery (CVIS) center in Southwest China. A total of 154 CVIS patients participated, with the intervention group receiving the WCPP and the control group following the traditional CVIS management program. Both groups were followed up at 1, 3, 6, and 12 months. The primary outcome is measured via the Chinese version of the 36-item Short Form Health Survey (SF-36). The Secondary outcomes included the 6-min walk test (6MWT), modified Barthel index (MBI), major adverse cardiovascular events (MACE), patient satisfaction, and length of hospital stay (LOS). Additionally, qualitative research will assess the psychological state and experiences of the patients.
Our study is one of the few involving patients with CVIS and the first to apply psycho-cardiology through a full-process management platform. The study population is predominantly from Southwest China and includes a diverse range of demographic and socioeconomic backgrounds. Upon completion, this study will provide valuable insights into the use of a remote, full-process management platform for CVIS patients.
Chinese Clinical Trial Registry ChiCTR2400081052. Registered on 21 February 2024. The trial complies with the SPIRIT and CONSORT guidelines.
瓣膜性心脏病是第三大常见的心血管疾病;它显著降低了患者的生活质量,并给个人、家庭和医疗保健系统带来了负担。近年来,心理心脏病学已成为探索精神疾病与心脏病之间关系的一个重要领域。这项混合方法研究旨在评估包括医院到家庭的过渡性护理、远程智能监测和决策辅助在内的 WCPP 在改善患者身心健康方面的有效性。
在中国西南部的一家心脏瓣膜介入手术(CVIS)中心进行了一项混合方法研究。共有 154 名 CVIS 患者参与,干预组接受 WCPP,对照组则采用传统的 CVIS 管理方案。两组均在 1、3、6 和 12 个月时进行随访。主要结局通过中文版 36 项简短健康调查(SF-36)进行测量。次要结局包括 6 分钟步行试验(6MWT)、改良巴氏指数(MBI)、主要不良心血管事件(MACE)、患者满意度和住院时间(LOS)。此外,定性研究将评估患者的心理状态和体验。
我们的研究是少数涉及 CVIS 患者的研究之一,也是首次通过全过程管理平台应用心理心脏病学。研究人群主要来自中国西南部,包括各种不同的人口统计学和社会经济背景。完成后,这项研究将为 CVIS 患者使用远程、全过程管理平台提供有价值的见解。
中国临床试验注册中心 ChiCTR2400081052。于 2024 年 2 月 21 日注册。试验符合 SPIRIT 和 CONSORT 指南。